tradingkey.logo

LENSAR Inc

LNSR

12.970USD

+0.360+2.85%
Horarios del mercado ETCotizaciones retrasadas 15 min
152.92MCap. mercado
PérdidaP/E TTM

LENSAR Inc

12.970

+0.360+2.85%
Más Datos de LENSAR Inc Compañía
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.
Información de la empresa
Símbolo de cotizaciónLNSR
Nombre de la empresaLENSAR Inc
Fecha de salida a bolsaSep 21, 2020
Director ejecutivoMr. Nicholas T. (Nick) Curtis
Número de empleados140
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 21
Dirección2800 Discovery Drive
CiudadORLANDO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal32826
Teléfono18885367271
Sitio Webhttps://www.lensar.com/
Símbolo de cotizaciónLNSR
Fecha de salida a bolsaSep 21, 2020
Director ejecutivoMr. Nicholas T. (Nick) Curtis
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
792.29K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
+1.36%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
+3.08%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
+8.62%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
+9.12%
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--
Mr. Todd B. Hammer
Mr. Todd B. Hammer
Independent Director
Independent Director
--
--
Mr. Thomas R. Staab, II
Mr. Thomas R. Staab, II
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Thomas B. Ellis
Mr. Thomas B. Ellis
Independent Director
Independent Director
--
--
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
792.29K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
+1.36%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
+3.08%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
+8.62%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
+9.12%
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
6.70M
54.57%
Asia (excluding South Korea)
3.08M
25.05%
Europe
2.25M
18.30%
South Korea
188.00K
1.53%
Other
67.00K
0.55%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mar., 29 de jul
Actualizado: mar., 29 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
North Run Capital, LP
9.33%
Curtis (Nicholas T)
6.72%
Link (William J)
4.67%
Brandes Investment Partners, L.P.
4.62%
Dimensional Fund Advisors, L.P.
4.05%
Other
70.61%
Accionistas
Accionistas
Proporción
North Run Capital, LP
9.33%
Curtis (Nicholas T)
6.72%
Link (William J)
4.67%
Brandes Investment Partners, L.P.
4.62%
Dimensional Fund Advisors, L.P.
4.05%
Other
70.61%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
19.94%
Hedge Fund
17.40%
Investment Advisor
15.80%
Investment Advisor/Hedge Fund
7.71%
Bank and Trust
1.44%
Research Firm
1.31%
Pension Fund
1.09%
Other
35.31%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
120
7.63M
64.70%
+228.90K
2025Q1
115
7.48M
63.69%
+236.19K
2024Q4
93
7.07M
60.29%
-575.26K
2024Q3
87
7.23M
62.19%
-377.24K
2024Q2
90
7.17M
61.87%
-380.16K
2024Q1
87
6.85M
59.77%
-601.54K
2023Q4
89
6.81M
60.46%
-688.43K
2023Q3
96
7.03M
62.74%
-797.20K
2023Q2
103
7.07M
63.18%
-1.15M
2023Q1
134
7.30M
65.81%
-830.17K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
North Run Capital, LP
1.10M
9.33%
--
--
Mar 23, 2025
Curtis (Nicholas T)
792.29K
6.72%
--
--
May 15, 2025
Link (William J)
550.64K
4.67%
+7.37K
+1.36%
May 23, 2025
Brandes Investment Partners, L.P.
544.69K
4.62%
+55.37K
+11.32%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
477.70K
4.05%
-136.68K
-22.25%
Mar 31, 2025
The Vanguard Group, Inc.
442.50K
3.75%
+9.02K
+2.08%
Mar 31, 2025
Renaissance Technologies LLC
313.64K
2.66%
-35.25K
-10.10%
Mar 31, 2025
Connaughton (Alan B.)
279.22K
2.37%
--
--
May 15, 2025
Tudor Investment Corporation
277.00K
2.35%
+277.00K
--
Mar 31, 2025
Lindstrom (Richard L)
246.41K
2.09%
+7.37K
+3.08%
May 23, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
Global X Russell 2000 ETF
0%
Ver más
iShares Micro-Cap ETF
Proporción0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.02%
iShares Russell 2000 Growth ETF
Proporción0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%
Franklin US Small Cap Multifactor Index ETF
Proporción0.01%
iShares Russell 2000 ETF
Proporción0%
Proshares Ultra Russell 2000
Proporción0%
ProShares UltraPro Russell2000
Proporción0%
Global X Russell 2000 ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI